Postpartum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.

Autor:	Fragoso, Yara Dadalti, Adoni, Tarso, Alves-Leon, Soniza Vieira, Azambuja, Nerio Dutra, Barreira, Amilton Antunes, Brooks, Joseph Bruno Bidin, Carneiro, Denise Sisteroli Diniz, Carvalho, Margarete J., Claudino, Rinaldo, Comini-Frota, Elizabeth Regina, Domingues, Renan Barros, Finkelsztejn, Alessandro, Gama, Paulo Diniz, Giacomo, Maria Cristina Brandao, Gomes, Sidney, Goncalves, Marcus Vinicius Magno, Grzesiuk, Anderson Kuntz, Kaimen-Maciel, Damacio Ramon, Mendes, Maria Fernanda, Morales, Nivea Macedo Oliveira
Předmět:	THERAPEUTIC use of immunoglobulins DISEASE relapse prevention CLINICAL trials STATISTICAL correlation FISHER exact test MOTHERS MULTIPLE sclerosis POSTNATAL care THIRD trimester of pregnancy T-test (Statistics) RETROSPECTIVE studies DATA analysis software
Zdroj:	Health Care for Women International; Oct2015, Vol. 36 Issue 10, p1072-1080, 9p, 1 Graph
Abstrakt:	Multiple sclerosis (MS) is a chronic, neurological, immune-mediated disease that can worsen in the postpartum period. There is no consensus on the use of immunoglobulin for prevention of disease relapses after delivery. We have shown that the controversial beneficial effect of immunoglobulin given immediately after birth could not be observed in patients with MS. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.